Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Roflumilast proven safe and effective in exercise-induced asthma

May 2, 2002

Idec extends IDEC-152 collaboration with Seikagaku

April 26, 2002

Altana and Pharmacia to codevelop and comarket roflumilast for respiratory conditions

April 26, 2002

Results from phase II study of IPL-576092 in asthma

April 26, 2002

Spiriva approved in E.U. under mutual recognition procedure

April 19, 2002

Histamine H3 receptor agonist discovered by European team

April 18, 2002

Alliance for research on interferon gamma-1b for asthma

April 15, 2002

Phase IB safety study of Moli-1901 in cystic fibrosis yields favorable results

April 15, 2002

Novartis presents data on the balanced NK1/NK2 antagonist DNK-333

April 15, 2002

Kitasato Institute reports development of antiinflammatory pseudoerythromycin derivatives

April 12, 2002

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....